ProShares Ultra Nasdaq Biotechnology
Limited financial coverage for BIB.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors.
- IPO
- 2010
- HQ
- Bethesda, MD, US
Price Chart
- Market Cap
- $88.68M
- Div Yield
- 0.46%
- 52W High
- $106.92
- 52W Low
- $46.38
- 50D MA
- $84.80
- 200D MA
- $79.25
- Beta
- 1.14
- Avg Volume
- 10.77K
Get TickerSpark's AI analysis on BIB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BIB coverage
Recent articles, reports, and earnings notes.
No research on BIB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIB report →Similar companies
Peers in the same neighborhood.